Synopsis
0
CEP/COS
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
96
PharmaCompass offers a list of Loxoprofen Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Loxoprofen Sodium manufacturer or Loxoprofen Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Loxoprofen Sodium manufacturer or Loxoprofen Sodium supplier.
A sodium loxoprofen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of sodium loxoprofen, including repackagers and relabelers. The FDA regulates sodium loxoprofen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. sodium loxoprofen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of sodium loxoprofen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A sodium loxoprofen supplier is an individual or a company that provides sodium loxoprofen active pharmaceutical ingredient (API) or sodium loxoprofen finished formulations upon request. The sodium loxoprofen suppliers may include sodium loxoprofen API manufacturers, exporters, distributors and traders.
click here to find a list of sodium loxoprofen suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A sodium loxoprofen DMF (Drug Master File) is a document detailing the whole manufacturing process of sodium loxoprofen active pharmaceutical ingredient (API) in detail. Different forms of sodium loxoprofen DMFs exist exist since differing nations have different regulations, such as sodium loxoprofen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A sodium loxoprofen DMF submitted to regulatory agencies in the US is known as a USDMF. sodium loxoprofen USDMF includes data on sodium loxoprofen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The sodium loxoprofen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of sodium loxoprofen suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The sodium loxoprofen Drug Master File in Japan (sodium loxoprofen JDMF) empowers sodium loxoprofen API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the sodium loxoprofen JDMF during the approval evaluation for pharmaceutical products. At the time of sodium loxoprofen JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of sodium loxoprofen suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a sodium loxoprofen Drug Master File in Korea (sodium loxoprofen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of sodium loxoprofen. The MFDS reviews the sodium loxoprofen KDMF as part of the drug registration process and uses the information provided in the sodium loxoprofen KDMF to evaluate the safety and efficacy of the drug.
After submitting a sodium loxoprofen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their sodium loxoprofen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of sodium loxoprofen suppliers with KDMF on PharmaCompass.
A sodium loxoprofen written confirmation (sodium loxoprofen WC) is an official document issued by a regulatory agency to a sodium loxoprofen manufacturer, verifying that the manufacturing facility of a sodium loxoprofen active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting sodium loxoprofen APIs or sodium loxoprofen finished pharmaceutical products to another nation, regulatory agencies frequently require a sodium loxoprofen WC (written confirmation) as part of the regulatory process.
click here to find a list of sodium loxoprofen suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing sodium loxoprofen as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for sodium loxoprofen API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture sodium loxoprofen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain sodium loxoprofen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a sodium loxoprofen NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of sodium loxoprofen suppliers with NDC on PharmaCompass.
sodium loxoprofen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of sodium loxoprofen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right sodium loxoprofen GMP manufacturer or sodium loxoprofen GMP API supplier for your needs.
A sodium loxoprofen CoA (Certificate of Analysis) is a formal document that attests to sodium loxoprofen's compliance with sodium loxoprofen specifications and serves as a tool for batch-level quality control.
sodium loxoprofen CoA mostly includes findings from lab analyses of a specific batch. For each sodium loxoprofen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
sodium loxoprofen may be tested according to a variety of international standards, such as European Pharmacopoeia (sodium loxoprofen EP), sodium loxoprofen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (sodium loxoprofen USP).
